Advances in the management of cutaneous squamous cell carcinoma

F1000Prime Reports

Volumn 6, Issue , 2014, Pages

  Parikh, Sonal A ^a   Patel, Vishal A ^a   Ratner, Desiree ^b  

^a Columbia University Department of Dermatology ^*  (United States)

^b BETH ISRAEL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOLEVULINIC ACID; AMINOLEVULINIC ACID METHYL ESTER; CAPECITABINE; CETUXIMAB; DICLOFENAC; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; FLUOROURACIL; GEFITINIB; IMIQUIMOD; INGENOL MEBUTATE; PANITUMUMAB; RETINOID;

ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER CLASSIFICATION; CANCER MORTALITY; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CHEMOSURGERY; CHRONIC WOUND; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE SEVERITY; FIELD CANCERIZATION THERAPY; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MOLECULARLY TARGETED THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHOTODYNAMIC THERAPY; RADIODIAGNOSIS; SENTINEL LYMPH NODE BIOPSY; SQUAMOUS CELL CARCINOMA;

EID: 84907002079     PISSN: 20517599     EISSN: 20517599     Source Type: Journal    
DOI: 10.12703/P6-70     Document Type: Article

References (69)

1. Karia PS, Han J, Schmults CD: Cutaneous squamous cell carcinoma: estimated incidence of disease, nodal metastasis, and deaths from disease in the United States, 2012. J Am Acad Dermatol 2013, 68:957-66.
2. Clayman GL, Lee JJ, Holsinger FC, Zhou X, Duvic M, El-Naggar AK, Prieto VG, Altamirano E, Tucker SL, Strom SS, Kripke ML, Lippman SM: Mortality risk from squamous cell skin cancer. J Clin Oncol 2005, 23:759-65.
3. Ross AS, Whalen FM, Elenitsas R, Xu X, Troxel AB, Schmults CD: Diameter of involved nerves predicts outcomes in cutaneous squamous cell carcinoma with perineural invasion: an investigator-blinded retrospective cohort study. Dermatol Surg 2009, 35:1859-66.
4. Karia PS, Jambusaria-Pahlajani A, Harrington DP, Murphy GF, Qureshi AA, Schmults CD: Evaluation of American Joint Committee on Cancer, International Union Against Cancer, and Brigham and Women 's Hospital tumor staging for cutaneous squamous cell carcinoma. J Clin Oncol 2014, 32:327-34.
5. Dinehart SM, Pollack SV: Metastases from squamous cell carcinoma of the skin and lip. An analysis of twenty-seven cases. J Am Acad Dermatol 1989, 21:241-8.
6. Miller SJ: Defining, treating, and studying very high-risk cutaneous squamous cell carcinomas. Arch Dermatol 2010, 146:1292-5.
7. Liu LS, Colegio OR: Molecularly targeted therapies for nonmelanoma skin cancers. Int J Dermatol 2013, 52:654-65.
8. Berg D, Otley CC: Skin cancer in organ transplant recipients: Epidemiology, pathogenesis, and management. J Am Acad Dermatol 2002, 47:1-17; quiz 18-20.
9. Herman S, Rogers HD, Ratner D: Immunosuppression and squamous cell carcinoma: a focus on solid organ transplant recipients. Skinmed 2007, 6:234-8.
10. Brantsch KD, Meisner C, Schönfisch B, Trilling B, Wehner-Caroli J, Röcken M, Breuninger H: Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. Lancet Oncol 2008, 9:713-20.
11. Smith KJ, Hamza S, Skelton H: Histologic features in primary cutaneous squamous cell carcinomas in immunocompromised patients focusing on organ transplant patients. Dermatol Surg 2004, 30:634-41.
12. Martorell-Calatayud A, Sanmartín Jimenez O, Cruz Mojarrieta J, Guillén Barona C: Cutaneous squamous cell carcinoma: defining the high-risk variant. Actas Dermosifiliogr 2013, 104:367-79.
13. Martinez J, Otley CC, Stasko T, Euvrard S, Brown C, Schanbacher CF, Weaver AL: Defining the clinical course of metastatic skin cancer in organ transplant recipients: a multicenter collaborative study. Arch Dermatol 2003, 139:301-6.
14. Frierson HF, Deutsch BD, Levine PA: Clinicopathologic features of cutaneous squamous cell carcinomas of the head and neck in patients with chronic lymphocytic leukemia/small lymphocytic lymphoma. Hum Pathol 1988, 19:1397-402.
15. Baskaynak G, Kreuzer K, Schwarz M, Zuber J, Audring H, Riess H, Dörken B, Le Coutre P: Squamous cutaneous epithelial cell carcinoma in two CML patients with progressive disease under imatinib treatment. Eur J Haematol 2003, 70:231-4.
16. De Luca, Jacqueline F, Severino R, Lee YS, Johnson D: Dermatologist and gastroenterologist awareness of the potential of immunosuppressants used to treat inflammatory bowel disease to cause non-melanoma skin cancer. Int J Dermatol 2013, 52:955-9.
17. van den Reek, JMPA, van Lümig, PPM, Janssen M, Schers HJ, Hendriks, JCM, van de Kerkhof, PCM, Seyger, MMB, de Jong, EMGJ: Increased incidence of squamous cell carcinoma of the skin after long-term treatment with azathioprine in patients with auto-immune inflammatory rheumatic diseases. J Eur Acad Dermatol Venereol 2014, 28:27-33.
18. Silverberg MJ, Leyden W, Warton EM, Quesenberry CP, Engels EA, Asgari MM: HIV infection status, immunodeficiency, and the incidence of non-melanoma skin cancer. J Natl Cancer Inst 2013, 105:350-60.
19. Hausauer AK, Maurer T, Leslie KS, Parvataneni R, Stuart SE, Chren M: Recurrence after treatment of cutaneous basal cell and squamous cell carcinomas in patients infected with human immunodeficiency virus. JAMA Dermatol 2013, 149:239-41.
20. Mullen JT, Feng L, Xing Y, Mansfield PF, Gershenwald JE, Lee JE, Ross MI, Cormier JN: Invasive squamous cell carcinoma of the skin: defining a high-risk group. Ann Surg Oncol 2006, 13:902-9.
21. Rowe DE, Carroll RJ, Day CL: Prognostic factors for local recurrence, metastasis, and survival rates in squamous cell carcinoma of the skin, ear, and lip. Implications for treatment modality selection. J Am Acad Dermatol 1992, 26:976-90.
22. Enoch S, Miller DR, Price PE, Harding KG: Early diagnosis is vital in the management of squamous cell carcinomas associated with chronic non healing ulcers: a case series and review of the literature. Int Wound J 2004, 1:165-75.
23. Lyakhovitsky A, Barzilai A, Fogel M, Trau H, Huszar M: Expression of e-cadherin and beta-catenin in cutaneous squamous cell carcinoma and its precursors. Am J Dermatopathol 2004, 26:372-8.
24. Fine J, Johnson LB, Weiner M, Li K, Suchindran C: Epidermolysis bullosa and the risk of life-threatening cancers: the National EB Registry experience, 1986-2006. J Am Acad Dermatol 2009, 60:203-11.
25. O'Bryan K, Sherman W, Niedt GW, Taback B, Manolidis S, Wang A, Ratner D: An evolving paradigm for the workup and management of high-risk cutaneous squamous cell carcinoma. J Am Acad Dermatol 2013, 69:595-602.e1.
26. Jambusaria-Pahlajani A, Kanetsky PA, Karia PS, Hwang W, Gelfand JM, Whalen FM, Elenitsas R, Xu X, Schmults CD: Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system. JAMA Dermatol 2013, 149:402-10.
27. Schmitt AR, Brewer JD, Bordeaux JS, Baum CL: Staging for cutaneous squamous cell carcinoma as a predictor of sentinel lymph node biopsy results: meta-analysis of American Joint Committee on Cancer criteria and a proposed alternative system. JAMA Dermatol 2014, 150:19-24.
28. Johnson TM, Rowe DE, Nelson BR, Swanson NA: Squamous cell carcinoma of the skin (excluding lip and oral mucosa). J Am Acad Dermatol 1992, 26:467-84.
29. Moore BA, Weber RS, Prieto V, El-Naggar A, Holsinger FC, Zhou X, Lee JJ, Lippman S, Clayman GL: Lymph node metastases from cutaneous squamous cell carcinoma of the head and neck. Laryngoscope 2005, 115:1561-7.
30. Yoon DY, Hwang HS, Chang SK, Rho Y, Ahn HY, Kim JH, Lee IJ: CT, MR, US,18F-FDG PET/CT, and their combined use for the assessment of cervical lymph node metastases in squamous cell carcinoma of the head and neck. Eur Radiol 2009, 19:634-42.
31. Jennings L, Schmults CD: Management of high-risk cutaneous squamous cell carcinoma. J Clin Aesthet Dermatol 2010, 3:39-48.
32. Jambusaria-Pahlajani A, Hess SD, Katz KA, Berg D, Schmults CD: Uncertainty in the perioperative management of high-risk cutaneous squamous cell carcinoma among Mohs surgeons. Arch Dermatol 2010, 146:1225-31.
33. Kwon S, Dong ZM, Wu PC: Sentinel lymph node biopsy for highrisk cutaneous squamous cell carcinoma: clinical experience and review of literature. World J Surg Oncol 2011, 9:80.
34. Swanson NA: Mohs surgery. Technique, indications, applications, and the future. Arch Dermatol 1983, 119:761-73.
35. Brodland DG, Zitelli JA: Surgical margins for excision of primary cutaneous squamous cell carcinoma. J Am Acad Dermatol 1992, 27:241-8.
36. Sober A: Cutaneous SCC and other cutaneous carcinomas. In In AJCC Cancer Staging Manual. 7th edition. Edited by Edge SB et al. New York: Springer; 2010.
37. Leibovitch I, Huilgol SC, Selva D, Hill D, Richards S, Paver R: Cutaneous squamous cell carcinoma treated with Mohs micrographic surgery in Australia I. Experience over 10 years. J Am Acad Dermatol 2005, 53:253-60.
38. Jambusaria-Pahlajani A, Miller CJ, Quon H, Smith N, Klein RQ, Schmults CD: Surgical monotherapy versus surgery plus adjuvant radiotherapy in high-risk cutaneous squamous cell carcinoma: a systematic review of outcomes. Dermatol Surg 2009, 35:574-85.
39. Belkin D, Carucci JA: Mohs surgery for squamous cell carcinoma. Dermatol Clin 2011, 29:161-74, vii.
40. Pugliano-Mauro M, Goldman G: Mohs surgery is effective for high-risk cutaneous squamous cell carcinoma. Dermatol Surg 2010, 36:1544-53.
41. Veness MJ, Ong C, Cakir B, Morgan G: Squamous cell carcinoma of the lip. Patterns of relapse and outcome: Reporting the Westmead Hospital experience, 1980-1997. Australas Radiol 2001, 45:195-9.
42. Caccialanza M, Piccinno R, Gaiani F, Contini D: Relevance of dermatologic radiotherapy in the therapeutic strategy of skin epithelial neoplasms: excellent results in the treatment of lesions localized on eyelids and skin overlying the cartilage of the nose. G Ital Dermatol Venereol 2013, 148:83-8.
43. Veness M, Richards S: Role of modern radiotherapy in treating skin cancer. Australas J Dermatol 2003, 44:159-66; quiz 167-8.
44. Al-Othman MO, Mendenhall WM, Amdur RJ: Radiotherapy alone for clinical T4 skin carcinoma of the head and neck with surgery reserved for salvage. Am J Otolaryngol 2001, 22:387-90.
45. Mendenhall WM, Amdur RJ, Hinerman RW, Cognetta AB, Mendenhall NP: Radiotherapy for cutaneous squamous and basal cell carcinomas of the head and neck. Laryngoscope 2009, 119:1994-9.
46. Shimizu T, Izumi H, Oga A, Furumoto H, Murakami T, Ofuji R, Muto M, Sasaki K: Epidermal growth factor receptor overexpression and genetic aberrations in metastatic squamouscell carcinoma of the skin. Dermatology (Basel) 2001, 202:203-6.
47. Uribe P, Gonzalez S: Epidermal growth factor receptor (EGFR) and squamous cell carcinoma of the skin: molecular bases for EGFR-targeted therapy. Pathol Res Pract 2011, 207:337-42.
48. Gaffney DC, Soyer HP, Simpson F: The epidermal growth factor receptor in squamous cell carcinoma: An emerging drug target. Australas J Dermatol 2014, 55:24-34.
49. Maubec E, Petrow P, Scheer-Senyarich I, Duvillard P, Lacroix L, Gelly J, Certain A, Duval X, Crickx B, Buffard V, Basset-Seguin N, Saez P, Duval-Modeste A, Adamski H, Mansard S, Grange F, Dompmartin A, Faivre S, Mentré F, Avril M: Phase II study of cetuximab as first-line single-drug therapy in patients with unresectable squamous cell carcinoma of the skin. J Clin Oncol 2011, 29:3419-26.
50. Eder J, Simonitsch-Klupp I, Trautinger F: Treatment of unresectable squamous cell carcinoma of the skin with epidermal growth factor receptor antibodies- a case series. Eur J Dermatol 2013, 23:658-62.
51. Heath CH, Deep NL, Nabell L, Carroll WR, Desmond R, Clemons L, Spencer S, Magnuson JS, Rosenthal EL: Phase 1 study of erlotinib plus radiation therapy in patients with advanced cutaneous squamous cell carcinoma. Int J Radiat Oncol Biol Phys 2013, 85:1275-81.
52. Choi D, Li ZJ, Chang I, Yeo M, Kim J, Sohn K, Im M, Seo Y, Lee J, Kim C, Lee Y: Clinicopathological roles of S100A8 and S100A9 in cutaneous squamous cell carcinoma in vivo and in vitro. Arch Dermatol Res 2014.
53. LeBoeuf NR, Schmults CD: Update on the management of highrisk squamous cell carcinoma. Semin CutanMed Surg 2011, 30:26-34.
54. Torezan, Luís Antônio Ribeiro, Festa-Neto C: Cutaneous field cancerization: clinical, histopathological and therapeutic aspects. An Bras Dermatol 2013, 88:775-86.
55. Lebwohl M, Swanson N, Anderson LL, Melgaard A, Xu Z, Berman B: Ingenol mebutate gel for actinic keratosis. N Engl J Med 2012, 366:1010-9.
56. Gupta AK, Paquet M, Villanueva E, Brintnell W: Interventions for actinic keratoses. Cochrane Database Syst Rev 2012, 12:CD004415.
57. Willey A, Mehta S, Lee PK: Reduction in the incidence of squamous cell carcinoma in solid organ transplant recipients treated with cyclic photodynamic therapy. Dermatol Surg 2010, 36:652-8.
58. Bavinck JN, Tieben LM, Van der Woude, FJ, Tegzess AM, Hermans J, ter Schegget J, Vermeer BJ: Prevention of skin cancer and reduction of keratotic skin lesions during acitretin therapy in renal transplant recipients: a double-blind, placebo-controlled study. J Clin Oncol 1995, 13:1933-8.
59. Wright TI, Spencer JM, Flowers FP: Chemoprevention of nonmelanoma skin cancer. J Am Acad Dermatol 2006, 54:933-46; quiz 947-50.
60. Otley CC, Stasko T, Tope WD, Lebwohl M: Chemoprevention of nonmelanoma skin cancer with systemic retinoids: practical dosing and management of adverse effects. Dermatol Surg 2006, 32:562-8.
61. Endrizzi BT, Lee PK: Management of carcinoma of the skin in solid organ transplant recipients with oral capecitabine. Dermatol Surg 2009, 35:1567-72.
62. Zwald FO, Brown M: Skin cancer in solid organ transplant recipients: advances in therapy and management: part II. Management of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011, 65:263-79; quiz 280.
63. Endrizzi B, Ahmed RL, Ray T, Dudek A, Lee P: Capecitabine to reduce nonmelanoma skin carcinoma burden in solid organ transplant recipients. Dermatol Surg 2013, 39:634-45.
64. Jirakulaporn T, Endrizzi B, Lindgren B, Mathew J, Lee PK, Dudek AZ: Capecitabine for skin cancer prevention in solid organ transplant recipients. Clin Transplant 2011, 25:541-8.
65. Bangash HK, Colegio OR: Management of non-melanoma skin cancer in immunocompromised solid organ transplant recipients. Curr Treat Options Oncol 2012, 13:354-76.
66. Scholten AN, Griep C, Davelaar J, Chin A, Leer JW: Elektronenbestraling effectief bij de behandeling van huidcarcinomen; een vergelijking met röntgencontacttherapie. Ned Tijdschr Geneeskd 1996, 140:428-31.
67. Locke J, Karimpour S, Young G, Lockett MA, Perez CA: Radiotherapy for epithelial skin cancer. Int J Radiat Oncol Biol Phys 2001, 51:748-55.
68. Lovett RD, Perez CA, Shapiro SJ, Garcia DM: External irradiation of epithelial skin cancer. Int J Radiat Oncol Biol Phys 1990, 19:235-42.
69. Kwan W, Wilson D, Moravan V: Radiotherapy for locally advanced basal cell and squamous cell carcinomas of the skin. Int J Radiat Oncol Biol Phys 2004, 60:406-11.